Earlier this year, researchers at Children's Hospital of Philadelphia and Penn created a first-of-its-kind drug customized to a unique genetic mutation to save an infant named Baby KJ from dying of a ...
Capital markets are generally efficient, and investors as a whole are not stupid — that is, there is wisdom of the crowd.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback